Literature DB >> 23644448

Upregulation of RCAN1 causes Down syndrome-like immune dysfunction.

Katherine R Martin1, Daniel Layton, Natalie Seach, Alicia Corlett, Maria Jose Barallobre, Maria L Arbonés, Richard L Boyd, Bernadette Scott, Melanie A Pritchard.   

Abstract

BACKGROUND: People with Down syndrome (DS) are more susceptible to infections and autoimmune disease, but the molecular genetic basis for these immune defects remains undetermined. In this study, we tested whether increased expression of the chromosome 21 gene RCAN1 contributes to immune dysregulation.
METHODS: We investigated the immune phenotype of a mouse model that overexpresses RCAN1. RCAN1 transgenic (TG) mice exhibit T cell abnormalities that bear a striking similarity to the abnormalities described in individuals with DS.
RESULTS: RCAN1-TG mice display T cell developmental defects in the thymus and peripheral immune tissues. Thymic cellularity is reduced by substantial losses of mature CD4 and CD8 thymocytes and medullary epithelium. In peripheral immune organs T lymphocytes are reduced in number and exhibit reduced proliferative capacity and aberrant cytokine production. These T cell defects are stem cell intrinsic in that transfer of wild type bone marrow into RCAN1-TG recipients restored medullary thymic epithelium and T cell numbers in the thymus, spleen and lymph nodes. However, bone marrow transplantation failed to improve T cell function, suggesting an additional role for RCAN1 in the non-haemopoietic compartment.
CONCLUSIONS: RCAN1 therefore facilitates T cell development and function, and when overexpressed, may contribute to immune dysfunction in DS.

Entities:  

Keywords:  Immunology (including allergy); Molecular genetics

Mesh:

Substances:

Year:  2013        PMID: 23644448     DOI: 10.1136/jmedgenet-2013-101522

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  7 in total

1.  RCAN1 Mutation and Functional Characterization in Children with Sporadic Congenital Heart Disease.

Authors:  Xiaoyong Li; Lei Shi; Ming Xu; Xun Zheng; Yiwen Yu; Jing Jin
Journal:  Pediatr Cardiol       Date:  2017-10-09       Impact factor: 1.655

2.  Bioinformatics analysis of biomarkers and transcriptional factor motifs in Down syndrome.

Authors:  X D Kong; N Liu; X J Xu
Journal:  Braz J Med Biol Res       Date:  2014-08-08       Impact factor: 2.590

3.  Regulator of Calcineurin 1 in Periodontal Disease.

Authors:  Ulrike Peters; Eleni Solominidou; Yüksel Korkmaz; Stefan Rüttermann; Astrid Klocke; Thomas Frank Flemmig; Thomas Beikler
Journal:  Mediators Inflamm       Date:  2016-06-15       Impact factor: 4.711

4.  Regulator of calcineurin 1 deletion attenuates mitochondrial dysfunction and apoptosis in acute kidney injury through JNK/Mff signaling pathway.

Authors:  Jing-Jie Xiao; Qing Liu; Ying Li; Fang-Fang Peng; Shan Wang; Zhihan Zhang; Hui Liu; Hong Yu; Shengxiang Tao; Bai-Fang Zhang
Journal:  Cell Death Dis       Date:  2022-09-07       Impact factor: 9.685

Review 5.  Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.

Authors:  Tomer Illouz; Arya Biragyn; Maria Florencia Iulita; Lisi Flores-Aguilar; Mara Dierssen; Ilario De Toma; Stylianos E Antonarakis; Eugene Yu; Yann Herault; Marie-Claude Potier; Alexandra Botté; Randall Roper; Benjamin Sredni; Jacqueline London; William Mobley; Andre Strydom; Eitan Okun
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

6.  RCAN1 regulates mitochondrial function and increases susceptibility to oxidative stress in mammalian cells.

Authors:  Heshan Peiris; Daphne Dubach; Claire F Jessup; Petra Unterweger; Ravinarayan Raghupathi; Hakan Muyderman; Mark P Zanin; Kimberly Mackenzie; Melanie A Pritchard; Damien J Keating
Journal:  Oxid Med Cell Longev       Date:  2014-06-09       Impact factor: 6.543

7.  RCAN1 in the inverse association between Alzheimer's disease and cancer.

Authors:  Qiang Fu; Yili Wu
Journal:  Oncotarget       Date:  2017-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.